USE OF 4- [7- (6-CIANO-5-TRIFLUOROMETILPIRIDIN-3-IL) -8-OXO-6-TIOXO-5,7-DIAZASPIRO [3,4] OCT-5-IL] -2-FLUORO- N-METHYLBENZAMIDE OR 4- [7- (4-CIANO-3-TRIFLUOROMETILPHENYL) -8-OXO-6-THIOXO-5,7-DIAZASPIRE [3,4] OCT-5-IL] -2-FLUORO-N- METHYLBENZAMIDE WITH A GONADOTROPINE FREEING HORMONE AGONIST TO TREAT PROSTATE CANCER.
USE OF 4- [7- (6-CIANO-5-TRIFLUOROMETILPIRIDIN-3-IL) -8-OXO-6-TIOXO-5,7-DIAZASPIRO [3,4] OCT-5-IL] -2-FLUORO- N-METHYLBENZAMIDE O 4- [7- (4-CIANO-3-TRIFLUOROMETILFENILO) -8-OXO-6-TIOXO-5,7-DIAZASPIRO [3,4] OCT-5-IL] -2-FLUORO-N- METHYLBENZAMIDE WITH A GONADOTROPIN-RELEASING HORMONE AGONIST TO TREAT PROSTATE CANCER.USO DE 4-[7-(6-CIANO-5-TRIFLUOROMETILPIRIDIN-3-IL)-8-OXO-6-TIOXO-5,7-DIAZASPIRO[3,4]OCT-5-IL]-2-FLUORO-N-METILBENZAMIDA O 4-[7-(4-CIANO-3-TRIFLUOROMETILFENILO)-8-OXO-6-TIOXO-5,7-DIAZASPIRO[3,4]OCT-5-IL]-2-FLUORO-N-METILBENZAMIDA CON UN AGONISTA DE LA HORMONA LIBERADORA DE GONADOTROPINA PARA TRATAR CÁNCER DE PRÓSTATA.